ONDANSETRON INJECTI
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2DP20F3782 is a delivery order issued under the primary contract SPE2DX15D9383 to DMS Pharmaceutical Group Inc. The procurement was managed by the DLA Troop Support Medical Supply Chain FSB for the acquisition of commercial items, specifically Ondansetron Injectable under NSN 6505015786170. The award was posted on August 25, 2026, and incorporates standard federal acquisition regulations and DLAD clauses. Subsequent to the initial award, modification P00001 was issued to effect a total cancellation of CLIN 0001. This action resulted in a total contract decrease of 20.66 dollars. The termination was executed for the convenience of the government under FAR 52.212-4(c) because the orders had aged and the ships intended to receive the supplies were being decommissioned, a decision to which the vendor agreed.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
